RGEN:NASDAQ
Repligen Corp
$168.53
arrow_upward
+0.55%(+0.93) 1D
$168.53
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 8, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$168.05
High
$172.94
Low
$166.32
Mkt. cap
9.51B
Avg. vol.
1.09M
Volume
779.44K
P/E ratio
229.72
52-wk high
$188.73
52-wk low
$100.99
EPS
$0.73
Beta
1.05
Shares outstanding
56.44M
No. of employees
2K
Open
$168.05
High
$172.94
Low
$166.32
Mkt. cap
9.51B
Avg. vol.
1.09M
Volume
779.44K
P/E ratio
229.72
52-wk high
$188.73
52-wk low
$100.99
EPS
$0.73
Beta
1.05
Shares outstanding
56.44M
No. of employees
2K
News stories
From web sources and news partners
TipRanks
·
2 hours ago
Repligen clears antitrust hurdle in BioLife Solutions acquisition
TradingView
·
3 hours ago
Repligen to acquire BioLife for $11.25 cash plus 0.1442 shares per BioLife share; HSR waiting period expired
Stock Titan
·
3 hours ago
[425] REPLIGEN CORP Business Combination Communication | RGEN SEC Filing - Form 425
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com